Since 2011, the Centers for Medicare & Medicaid Services (CMS) has seen a reduction of in long-stay nursing home residents who were receiving an antipsychotic medication. Despite the success of the National Partnership, as of January 2019, there are 235 late adopter nursing homes that have been cited for noncompliance with federal regulations related to unnecessary medications or psychotropic medications two or more times since January 1, 2016, and who have not shown improvement in their long-stay antipsychotic medication rates. If these facilities are determined not to be in substantial compliance with requirements for Chemical Restraints, Dementia Care, or Psychotropic Medications during a survey, they will be subject to enforcement remedies for such noncompliance.

Read the full memo HERE.